OSENAT AREMU: Open Payments
NPI 1356121719 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,226 in 15 payments from 4 companies in 2025. Trend: 2023 $288 · 2024 $729 · 2025 $1,226
Food & beverage: $1,226
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $611 |
| Otsuka America Pharmaceutical, Inc. | 2 | $237 |
| Janssen Pharmaceuticals, Inc | 3 | $201 |
| ABBVIE INC. | 5 | $177 |
Products named: CAPLYTA, INVEGA SUSTENNA, VRAYLAR, REXULTI, ABILIFY MAINTENA.
Industry payments across MD — which companies pay providers there.
